Aesyra secures USD 3 Million in funding to advance AesyBite™ products for sleep bruxism and sleep apnea
13.12.2023
Aesyra is set to make great steps forward in improving sleep health. The latest funding injection will empower the company to further innovate and address the growing demand for advanced solutions in the field of sleep disorders.
 Aesyra's team
|
 |
Aesyra, an EPFL spin-off, has developed an innovative technology system addressing sleep bruxism, a prevalent sleep disorder often associated with sleep apnea, impacting nearly a billion individuals globally. Combining a distinctive oral appliance device with proprietary sensors, Aesyra's AesyBite™ has demonstrated a remarkable 70% reduction in bruxism activity, driven by innovative technologies and algorithms grounded in years of sleep research data.
“This significant investment marks a pivotal moment for Aesyra,” said Marco Letizia, founder and CEO of Aesyra. “We are thrilled to partner with Supermoon Capital and Creadd Ventures, who share our vision of driving meaningful change within the sleep industry. With their support, we are well-positioned to accelerate the deployment of our groundbreaking solutions, ultimately improving patient outcomes and advancing healthcare practices.”
Aesyra won the first stage of the Venture Kick program in 2017.
Aesyra's team
“This significant investment marks a pivotal moment for Aesyra,” said Marco Letizia, founder and CEO of Aesyra. “We are thrilled to partner with Supermoon Capital and Creadd Ventures, who share our vision of driving meaningful change within the sleep industry. With their support, we are well-positioned to accelerate the deployment of our groundbreaking solutions, ultimately improving patient outcomes and advancing healthcare practices.”
Aesyra won the first stage of the Venture Kick program in 2017.
Aesyra's team